APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gout Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gout Drugs Market Analysis and Forecast 2026-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchGout Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Gout Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Gout Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gout Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Gout Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gout Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gout Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gout Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gout Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gout Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gout Drugs include Accord, Apotex, Ipca, KPC, Northstar, PIDI, Synpac-Kingdom, Mylan and Sun Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gout Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gout Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Gout Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gout Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gout Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gout Drugs sales, projected growth trends, production technology, application and end-user industry.

Gout Drugs Segment by Company

Accord

Apotex

Ipca

KPC

Northstar

PIDI

Synpac-Kingdom

Mylan

Sun Pharma

Yunnan Phytopharmaceutical

Gout Drugs Segment by Type

Benzbromo Malone

Allopurinol

Febuxostat

Colchicine

Other

Gout Drugs Segment by Application

Acute gout

Chronic gout

Gout Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gout Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gout Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gout Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gout Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gout Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gout Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gout Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Benzbromo Malone Major Manufacturers Table 3. Allopurinol Major Manufacturers Table 4. Febuxostat Major Manufacturers Table 5. Colchicine Major Manufacturers Table 6. Other Major Manufacturers Table 7. Global Gout Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Acute gout Major Manufacturers Table 9. Chronic gout Major Manufacturers Table 10. Gout Drugs Industry Trends Table 11. Gout Drugs Industry Drivers Table 12. Gout Drugs Industry Opportunities and Challenges Table 13. Gout Drugs Industry Restraints Table 14. Global Gout Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Gout Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Gout Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Gout Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Gout Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Gout Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gout Drugs Sales by Region (2021-2026) & (K Units) Table 21. Global Gout Drugs Sales by Region (2027-2032) & (K Units) Table 22. Global Gout Drugs Sales Market Share by Region (2021-2026) Table 23. Global Gout Drugs Sales Market Share by Region (2027-2032) Table 24. Global Gout Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Gout Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Gout Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Gout Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Gout Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Gout Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Gout Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Gout Drugs Manufacturers, Product Type & Application Table 32. Global Gout Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Gout Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Gout Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gout Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Gout Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Gout Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Gout Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Gout Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Gout Drugs Sales by Type (2021-2026) & (K Units) Table 42. Global Gout Drugs Sales by Type (2027-2032) & (K Units) Table 43. Global Gout Drugs Sales Market Share by Type (2021-2026) Table 44. Global Gout Drugs Sales Market Share by Type (2027-2032) Table 45. Global Gout Drugs Price by Type (2021-2026) & (US$/Unit) Table 46. Global Gout Drugs Price by Type (2027-2032) & (US$/Unit) Table 47. Global Gout Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gout Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Gout Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Gout Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Gout Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Gout Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Gout Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Gout Drugs Sales by Application (2027-2032) & (K Units) Table 55. Global Gout Drugs Sales Market Share by Application (2021-2026) Table 56. Global Gout Drugs Sales Market Share by Application (2027-2032) Table 57. Global Gout Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Gout Drugs Price by Application (2027-2032) & (US$/Unit) Table 59. Accord Company Information Table 60. Accord Business Overview Table 61. Accord Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Accord Gout Drugs Product Portfolio Table 63. Accord Recent Development Table 64. Apotex Company Information Table 65. Apotex Business Overview Table 66. Apotex Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Apotex Gout Drugs Product Portfolio Table 68. Apotex Recent Development Table 69. Ipca Company Information Table 70. Ipca Business Overview Table 71. Ipca Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Ipca Gout Drugs Product Portfolio Table 73. Ipca Recent Development Table 74. KPC Company Information Table 75. KPC Business Overview Table 76. KPC Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. KPC Gout Drugs Product Portfolio Table 78. KPC Recent Development Table 79. Northstar Company Information Table 80. Northstar Business Overview Table 81. Northstar Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Northstar Gout Drugs Product Portfolio Table 83. Northstar Recent Development Table 84. PIDI Company Information Table 85. PIDI Business Overview Table 86. PIDI Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. PIDI Gout Drugs Product Portfolio Table 88. PIDI Recent Development Table 89. Synpac-Kingdom Company Information Table 90. Synpac-Kingdom Business Overview Table 91. Synpac-Kingdom Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Synpac-Kingdom Gout Drugs Product Portfolio Table 93. Synpac-Kingdom Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mylan Gout Drugs Product Portfolio Table 98. Mylan Recent Development Table 99. Sun Pharma Company Information Table 100. Sun Pharma Business Overview Table 101. Sun Pharma Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sun Pharma Gout Drugs Product Portfolio Table 103. Sun Pharma Recent Development Table 104. Yunnan Phytopharmaceutical Company Information Table 105. Yunnan Phytopharmaceutical Business Overview Table 106. Yunnan Phytopharmaceutical Gout Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Yunnan Phytopharmaceutical Gout Drugs Product Portfolio Table 108. Yunnan Phytopharmaceutical Recent Development Table 109. North America Gout Drugs Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Gout Drugs Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Gout Drugs Sales by Type (2021-2026) & (K Units) Table 112. North America Gout Drugs Sales by Type (2027-2032) & (K Units) Table 113. North America Gout Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 114. North America Gout Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 115. North America Gout Drugs Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Gout Drugs Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Gout Drugs Sales by Application (2021-2026) & (K Units) Table 118. North America Gout Drugs Sales by Application (2027-2032) & (K Units) Table 119. North America Gout Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 120. North America Gout Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 121. North America Gout Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Gout Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. North America Gout Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. North America Gout Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. North America Gout Drugs Sales by Country (2021-2026) & (K Units) Table 126. North America Gout Drugs Sales by Country (2027-2032) & (K Units) Table 127. North America Gout Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 128. North America Gout Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 129. United States Gout Drugs Revenue (2021-2032) & (US$ Million) Table 130. Canada Gout Drugs Revenue (2021-2032) & (US$ Million) Table 131. Europe Gout Drugs Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Gout Drugs Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Gout Drugs Sales by Type (2021-2026) & (K Units) Table 134. Europe Gout Drugs Sales by Type (2027-2032) & (K Units) Table 135. Europe Gout Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Europe Gout Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Europe Gout Drugs Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Gout Drugs Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Gout Drugs Sales by Application (2021-2026) & (K Units) Table 140. Europe Gout Drugs Sales by Application (2027-2032) & (K Units) Table 141. Europe Gout Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Europe Gout Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Europe Gout Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Gout Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Gout Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Gout Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Europe Gout Drugs Sales by Country (2021-2026) & (K Units) Table 148. Europe Gout Drugs Sales by Country (2027-2032) & (K Units) Table 149. Europe Gout Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Europe Gout Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Germany Gout Drugs Revenue (2021-2032) & (US$ Million) Table 152. France Gout Drugs Revenue (2021-2032) & (US$ Million) Table 153. U.K. Gout Drugs Revenue (2021-2032) & (US$ Million) Table 154. Italy Gout Drugs Revenue (2021-2032) & (US$ Million) Table 155. Netherlands Gout Drugs Revenue (2021-2032) & (US$ Million) Table 156. Nordic Countries Gout Drugs Revenue (2021-2032) & (US$ Million) Table 157. China Gout Drugs Revenue by Type (2021-2026) & (US$ Million) Table 158. China Gout Drugs Revenue by Type (2027-2032) & (US$ Million) Table 159. China Gout Drugs Sales by Type (2021-2026) & (K Units) Table 160. China Gout Drugs Sales by Type (2027-2032) & (K Units) Table 161. China Gout Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 162. China Gout Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 163. China Gout Drugs Revenue by Application (2021-2026) & (US$ Million) Table 164. China Gout Drugs Revenue by Application (2027-2032) & (US$ Million) Table 165. China Gout Drugs Sales by Application (2021-2026) & (K Units) Table 166. China Gout Drugs Sales by Application (2027-2032) & (K Units) Table 167. China Gout Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 168. China Gout Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Gout Drugs Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Gout Drugs Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Gout Drugs Sales by Type (2021-2026) & (K Units) Table 172. Asia Gout Drugs Sales by Type (2027-2032) & (K Units) Table 173. Asia Gout Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 174. Asia Gout Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 175. Asia Gout Drugs Revenue by Application (2021-2026) & (US$ Million) Table 176. Asia Gout Drugs Revenue by Application (2027-2032) & (US$ Million) Table 177. Asia Gout Drugs Sales by Application (2021-2026) & (K Units) Table 178. Asia Gout Drugs Sales by Application (2027-2032) & (K Units) Table 179. Asia Gout Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 180. Asia Gout Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 181. Asia Gout Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Asia Gout Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Asia Gout Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Asia Gout Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. Asia Gout Drugs Sales by Country (2021-2026) & (K Units) Table 186. Asia Gout Drugs Sales by Country (2027-2032) & (K Units) Table 187. Asia Gout Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 188. Asia Gout Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Japan Gout Drugs Revenue (2021-2032) & (US$ Million) Table 190. South Korea Gout Drugs Revenue (2021-2032) & (US$ Million) Table 191. India Gout Drugs Revenue (2021-2032) & (US$ Million) Table 192. Australia Gout Drugs Revenue (2021-2032) & (US$ Million) Table 193. China Taiwan Gout Drugs Revenue (2021-2032) & (US$ Million) Table 194. Southeast Asia Gout Drugs Revenue (2021-2032) & (US$ Million) Table 195. SAMEA Gout Drugs Revenue by Type (2021-2026) & (US$ Million) Table 196. SAMEA Gout Drugs Revenue by Type (2027-2032) & (US$ Million) Table 197. SAMEA Gout Drugs Sales by Type (2021-2026) & (K Units) Table 198. SAMEA Gout Drugs Sales by Type (2027-2032) & (K Units) Table 199. SAMEA Gout Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 200. SAMEA Gout Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 201. SAMEA Gout Drugs Revenue by Application (2021-2026) & (US$ Million) Table 202. SAMEA Gout Drugs Revenue by Application (2027-2032) & (US$ Million) Table 203. SAMEA Gout Drugs Sales by Application (2021-2026) & (K Units) Table 204. SAMEA Gout Drugs Sales by Application (2027-2032) & (K Units) Table 205. SAMEA Gout Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 206. SAMEA Gout Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 207. SAMEA Gout Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. SAMEA Gout Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. SAMEA Gout Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. SAMEA Gout Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 211. SAMEA Gout Drugs Sales by Country (2021-2026) & (K Units) Table 212. SAMEA Gout Drugs Sales by Country (2027-2032) & (K Units) Table 213. SAMEA Gout Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 214. SAMEA Gout Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 215. Brazil Gout Drugs Revenue (2021-2032) & (US$ Million) Table 216. Argentina Gout Drugs Revenue (2021-2032) & (US$ Million) Table 217. Chile Gout Drugs Revenue (2021-2032) & (US$ Million) Table 218. Colombia Gout Drugs Revenue (2021-2032) & (US$ Million) Table 219. Peru Gout Drugs Revenue (2021-2032) & (US$ Million) Table 220. Saudi Arabia Gout Drugs Revenue (2021-2032) & (US$ Million) Table 221. Israel Gout Drugs Revenue (2021-2032) & (US$ Million) Table 222. UAE Gout Drugs Revenue (2021-2032) & (US$ Million) Table 223. Turkey Gout Drugs Revenue (2021-2032) & (US$ Million) Table 224. Iran Gout Drugs Revenue (2021-2032) & (US$ Million) Table 225. Egypt Gout Drugs Revenue (2021-2032) & (US$ Million) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Gout Drugs Distributors List Table 229. Gout Drugs Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Gout Drugs Image Figure 2. Global Gout Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gout Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Benzbromo Malone Image Figure 5. Allopurinol Image Figure 6. Febuxostat Image Figure 7. Colchicine Image Figure 8. Other Image Figure 9. Global Gout Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Gout Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Acute gout Image Figure 12. Chronic gout Image Figure 13. Global Gout Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gout Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Gout Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Gout Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Gout Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Gout Drugs Sales (2021-2032) & (K Units) Figure 19. Global Gout Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Gout Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Gout Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Europe Gout Drugs Sales YoY (2021-2032) & (K Units) Figure 23. China Gout Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Gout Drugs Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Gout Drugs Sales YoY (2021-2032) & (K Units) Figure 26. Global Gout Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Gout Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Gout Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Gout Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Gout Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Gout Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Gout Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gout Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Gout Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Gout Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Gout Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Gout Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Gout Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gout Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Gout Drugs Revenue Share by Type (2021-2032) Figure 42. North America Gout Drugs Sales Share by Type (2021-2032) Figure 43. North America Gout Drugs Revenue Share by Application (2021-2032) Figure 44. North America Gout Drugs Sales Share by Application (2021-2032) Figure 45. North America Gout Drugs Revenue Share by Country (2021-2032) Figure 46. North America Gout Drugs Sales Share by Country (2021-2032) Figure 47. Europe Gout Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Gout Drugs Sales Share by Type (2021-2032) Figure 49. Europe Gout Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Gout Drugs Sales Share by Application (2021-2032) Figure 51. Europe Gout Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Gout Drugs Sales Share by Country (2021-2032) Figure 53. China Gout Drugs Revenue Share by Type (2021-2032) Figure 54. China Gout Drugs Sales Share by Type (2021-2032) Figure 55. China Gout Drugs Revenue Share by Application (2021-2032) Figure 56. China Gout Drugs Sales Share by Application (2021-2032) Figure 57. Asia Gout Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Gout Drugs Sales Share by Type (2021-2032) Figure 59. Asia Gout Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Gout Drugs Sales Share by Application (2021-2032) Figure 61. Asia Gout Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Gout Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Gout Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Gout Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Gout Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Gout Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Gout Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Gout Drugs Sales Share by Country (2021-2032) Figure 69. Gout Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Gout Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Benzbromo Malone
  • Allopurinol
  • Febuxostat
  • Colchicine
  • Other
Applications
  • Acute gout
  • Chronic gout
Companies covered
  • Accord
  • Apotex
  • Ipca
  • KPC
  • Northstar
  • PIDI
  • Synpac-Kingdom
  • Mylan
  • Sun Pharma
  • Yunnan Phytopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gout Drugs Market by Type
  3. 1.2.1 Global Gout Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Benzbromo Malone
  5. 1.2.3 Allopurinol
  6. 1.2.4 Febuxostat
  7. 1.2.5 Colchicine
  8. 1.2.6 Other
  9. 1.3 Gout Drugs Market by Application
  10. 1.3.1 Global Gout Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Acute gout
  12. 1.3.3 Chronic gout
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gout Drugs Market Dynamics
  1. 2.1 Gout Drugs Industry Trends
  2. 2.2 Gout Drugs Industry Drivers
  3. 2.3 Gout Drugs Industry Opportunities and Challenges
  4. 2.4 Gout Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gout Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gout Drugs Revenue by Region
  3. 3.2.1 Global Gout Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gout Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Gout Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Gout Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gout Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gout Drugs Sales by Region
  9. 3.4.1 Global Gout Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gout Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Gout Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Gout Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gout Drugs Revenue by Manufacturers
  2. 4.1.1 Global Gout Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gout Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gout Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gout Drugs Sales by Manufacturers
  6. 4.2.1 Global Gout Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gout Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gout Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gout Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gout Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gout Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gout Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Gout Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gout Drugs Market CR5 and HHI
  16. 4.8.2 2025 Gout Drugs Tier 1, Tier 2, and Tier 3
5 Gout Drugs Market by Type
  1. 5.1 Global Gout Drugs Revenue by Type
  2. 5.1.1 Global Gout Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gout Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gout Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gout Drugs Sales by Type
  6. 5.2.1 Global Gout Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gout Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gout Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gout Drugs Price by Type
6 Gout Drugs Market by Application
  1. 6.1 Global Gout Drugs Revenue by Application
  2. 6.1.1 Global Gout Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gout Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gout Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gout Drugs Sales by Application
  6. 6.2.1 Global Gout Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gout Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gout Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gout Drugs Price by Application
7 Company Profiles
  1. 7.1 Accord
  2. 7.1.1 Accord Company Information
  3. 7.1.2 Accord Business Overview
  4. 7.1.3 Accord Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Accord Gout Drugs Product Portfolio
  6. 7.1.5 Accord Recent Developments
  7. 7.2 Apotex
  8. 7.2.1 Apotex Company Information
  9. 7.2.2 Apotex Business Overview
  10. 7.2.3 Apotex Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Apotex Gout Drugs Product Portfolio
  12. 7.2.5 Apotex Recent Developments
  13. 7.3 Ipca
  14. 7.3.1 Ipca Company Information
  15. 7.3.2 Ipca Business Overview
  16. 7.3.3 Ipca Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ipca Gout Drugs Product Portfolio
  18. 7.3.5 Ipca Recent Developments
  19. 7.4 KPC
  20. 7.4.1 KPC Company Information
  21. 7.4.2 KPC Business Overview
  22. 7.4.3 KPC Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 KPC Gout Drugs Product Portfolio
  24. 7.4.5 KPC Recent Developments
  25. 7.5 Northstar
  26. 7.5.1 Northstar Company Information
  27. 7.5.2 Northstar Business Overview
  28. 7.5.3 Northstar Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Northstar Gout Drugs Product Portfolio
  30. 7.5.5 Northstar Recent Developments
  31. 7.6 PIDI
  32. 7.6.1 PIDI Company Information
  33. 7.6.2 PIDI Business Overview
  34. 7.6.3 PIDI Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 PIDI Gout Drugs Product Portfolio
  36. 7.6.5 PIDI Recent Developments
  37. 7.7 Synpac-Kingdom
  38. 7.7.1 Synpac-Kingdom Company Information
  39. 7.7.2 Synpac-Kingdom Business Overview
  40. 7.7.3 Synpac-Kingdom Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Synpac-Kingdom Gout Drugs Product Portfolio
  42. 7.7.5 Synpac-Kingdom Recent Developments
  43. 7.8 Mylan
  44. 7.8.1 Mylan Company Information
  45. 7.8.2 Mylan Business Overview
  46. 7.8.3 Mylan Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mylan Gout Drugs Product Portfolio
  48. 7.8.5 Mylan Recent Developments
  49. 7.9 Sun Pharma
  50. 7.9.1 Sun Pharma Company Information
  51. 7.9.2 Sun Pharma Business Overview
  52. 7.9.3 Sun Pharma Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sun Pharma Gout Drugs Product Portfolio
  54. 7.9.5 Sun Pharma Recent Developments
  55. 7.10 Yunnan Phytopharmaceutical
  56. 7.10.1 Yunnan Phytopharmaceutical Company Information
  57. 7.10.2 Yunnan Phytopharmaceutical Business Overview
  58. 7.10.3 Yunnan Phytopharmaceutical Gout Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Yunnan Phytopharmaceutical Gout Drugs Product Portfolio
  60. 7.10.5 Yunnan Phytopharmaceutical Recent Developments
8 North America
  1. 8.1 North America Gout Drugs Market Size by Type
  2. 8.1.1 North America Gout Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Gout Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Gout Drugs Price by Type (2021-2032)
  5. 8.2 North America Gout Drugs Market Size by Application
  6. 8.2.1 North America Gout Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Gout Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Gout Drugs Price by Application (2021-2032)
  9. 8.3 North America Gout Drugs Market Size by Country
  10. 8.3.1 North America Gout Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gout Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gout Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gout Drugs Market Size by Type
  2. 9.1.1 Europe Gout Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gout Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Gout Drugs Price by Type (2021-2032)
  5. 9.2 Europe Gout Drugs Market Size by Application
  6. 9.2.1 Europe Gout Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gout Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Gout Drugs Price by Application (2021-2032)
  9. 9.3 Europe Gout Drugs Market Size by Country
  10. 9.3.1 Europe Gout Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gout Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gout Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Gout Drugs Market Size by Type
  2. 10.1.1 China Gout Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Gout Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Gout Drugs Price by Type (2021-2032)
  5. 10.2 China Gout Drugs Market Size by Application
  6. 10.2.1 China Gout Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Gout Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Gout Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gout Drugs Market Size by Type
  2. 11.1.1 Asia Gout Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gout Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Gout Drugs Price by Type (2021-2032)
  5. 11.2 Asia Gout Drugs Market Size by Application
  6. 11.2.1 Asia Gout Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gout Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Gout Drugs Price by Application (2021-2032)
  9. 11.3 Asia Gout Drugs Market Size by Country
  10. 11.3.1 Asia Gout Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gout Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gout Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gout Drugs Market Size by Type
  2. 12.1.1 SAMEA Gout Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gout Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gout Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Gout Drugs Market Size by Application
  6. 12.2.1 SAMEA Gout Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gout Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gout Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Gout Drugs Market Size by Country
  10. 12.3.1 SAMEA Gout Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gout Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gout Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gout Drugs Value Chain Analysis
  2. 13.1.1 Gout Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gout Drugs Production Mode & Process
  6. 13.2 Gout Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gout Drugs Distributors
  9. 13.2.3 Gout Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst